Cumulative live birth rate after cleavage-stage(day three) or blastocyst stage(day five) embryo transfer in good prognosis IVF/ICSI cycles.
Completed
- Conditions
- Assisted reproductionInfertility1002892010013356
- Registration Number
- NL-OMON50232
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1202
Inclusion Criteria
-Women 18-42 years
-IVF/ICSI treatment with at least 4 embryos on culture day 2 available.
-Written informed consent
Exclusion Criteria
-Preimplantation genetic diagnosis (PGD)cycles
-The use of vitrified oocytes
-Participating in interfering study
-Patients can only participate one IVF-cycle
-The use of donated oocytes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary aim is to study whether blastocyst stage embryo transfers (day 5)<br /><br>improves the cumulative LBR in IVF/ ICSI<br /><br>patients with a good prognosis (> 3 embryo's on day 2 after oocyte retrieval).</p><br>
- Secondary Outcome Measures
Name Time Method